دورية أكاديمية

Should lithium be used in children and adolescents with bipolar disorder?

التفاصيل البيبلوغرافية
العنوان: Should lithium be used in children and adolescents with bipolar disorder?
المؤلفون: Salazar de Pablo G; Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK; Child and Adolescent Mental Health Services, South London and Maudsley NHS Foundation Trust, UK; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón School of Medicine, Universidad Complutense, IiSGM, CIBERSAM, Madrid, Spain. Electronic address: gonzalo.salazar_de_pablo@kcl.ac.uk., Young AH; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Kent, UK.
المصدر: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology [Eur Neuropsychopharmacol] 2024 May; Vol. 82, pp. 1-2. Date of Electronic Publication: 2024 Feb 03.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9111390 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7862 (Electronic) Linking ISSN: 0924977X NLM ISO Abbreviation: Eur Neuropsychopharmacol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Amsterdam : Elsevier, c1990-
مواضيع طبية MeSH: Bipolar Disorder*/drug therapy , Lithium Compounds*/therapeutic use, Humans ; Adolescent ; Child ; Antimanic Agents/therapeutic use
مستخلص: Competing Interests: Declaration of competing interest Dr Salazar de Pablo has received honoraria from: Janssen-Cilag, Lundbeck, Menarini and Angelini. Prof Young has received compensation for lectures or advisory boards from the following companies: AstraZeneca, Boehringer Ingelheim, Eli Lilly, LivaNova, Lundbeck, Sunovion, Servier, Janssen, Allegan, Bionomics, Sumitomo Dainippon Pharma, COMPASS, Sage, Novartis, and Neurocentrx.
المشرفين على المادة: 0 (Lithium Compounds)
0 (Antimanic Agents)
تواريخ الأحداث: Date Created: 20240204 Date Completed: 20240502 Latest Revision: 20240502
رمز التحديث: 20240503
DOI: 10.1016/j.euroneuro.2024.01.007
PMID: 38310671
قاعدة البيانات: MEDLINE
الوصف
تدمد:1873-7862
DOI:10.1016/j.euroneuro.2024.01.007